1-3 of 3
Yoo-Li Kim
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcome of Patients with Chronic Myeloid Leukemia Who Recieved an Intermittent Imatinib Therapy.

Hyun-Gyung Goh, MS, Soo-Hyun Kim, BA, Jeong Lee, MS, Sae-Eun Jang, BA, Wan-Seok Kim, PhD, Yoo-Li Kim, MS, Sa-Hee Park, BA, Il-Young Kwon, BA, Dong-Wook Kim, MD, PhD
Journal: Blood
Blood (2007) 110 (11): 1034.
https://doi.org/10.1182/blood.V110.11.1034.1034
Published: 2007
Journal Articles

Cotransplantation of third-party mesenchymal stromal cells can alleviate single-donor predominance and increase engraftment from double cord transplantation

Dong-Wook Kim, Yang-Jo Chung, Tai-Gyu Kim, Yoo-Li Kim, Il-Hoan Oh
Journal: Blood
Blood (2004) 103 (5): 1941–1948.
https://doi.org/10.1182/blood-2003-05-1601
Published: 2004
Journal Articles

Minimal residual disease–based role of imatinib as a first-line interim therapy prior to allogeneic stem cell transplantation in Philadelphia chromosome–positive acute lymphoblastic leukemia

Clinical Trials & Observations Brief Report
Seok Lee, Dong-Wook Kim, Yoo-Jin Kim, Nak-Gyun Chung, Yoo-Li Kim, Ji-Yeon Hwang, Chun-Choo Kim
Journal: Blood
Blood (2003) 102 (8): 3068–3070.
https://doi.org/10.1182/blood-2003-04-1180
Published: 2003